Sanders Morris Harris LLC Invests $201,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sanders Morris Harris LLC purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,488 shares of the company’s stock, valued at approximately $201,000.

Separately, Czech National Bank acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at $3,750,000. Hedge funds and other institutional investors own 79.18% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Kevin Michael O’neill sold 15,609 shares of GE HealthCare Technologies stock in a transaction on Monday, July 31st. The stock was sold at an average price of $77.32, for a total transaction of $1,206,887.88. Following the sale, the chief executive officer now directly owns 24,025 shares in the company, valued at approximately $1,857,613. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.21% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on GEHC. Morgan Stanley began coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 27th. They issued an “equal weight” rating for the company. Bank of America began coverage on shares of GE HealthCare Technologies in a research report on Monday, July 31st. They issued a “neutral” rating and a $82.00 price target for the company. Argus started coverage on shares of GE HealthCare Technologies in a research report on Friday, August 25th. They issued a “buy” rating and a $80.00 price target for the company. Finally, Wells Fargo & Company started coverage on GE HealthCare Technologies in a research note on Wednesday, August 16th. They set an “overweight” rating and a $90.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $89.25.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $66.43 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $53.00 and a 1-year high of $87.83. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.92 and a current ratio of 1.22. The stock’s fifty day simple moving average is $73.37 and its two-hundred day simple moving average is $77.06.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Tuesday, July 25th. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.05. The business had revenue of $4.82 billion for the quarter, compared to the consensus estimate of $4.79 billion. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Research analysts expect that GE HealthCare Technologies Inc. will post 3.8 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Friday, July 21st were paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.18%. The ex-dividend date was Thursday, July 20th.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.